In vitro and in vivo evaluation of C-20- and C-23-modified derivatives of tylosin against veterinary pathogens

10Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Three series of semi-synthetic derivatives of tylosin-related macrolides were evaluated for utility in veterinary medicine. 23-Modified derivatives of 5-O-mycaminosyltylonolide (OMT) possessed potent activity in vitro against species of Pasteurella and Mycoplasma. An experimental infection in chicks caused by Pasteurella multocida was utilized to evaluate efficacy; several of these derivatives of OMT effectively treated the infection when given subcutaneously, but none were effective after oral administration in drinking water. Macrolides retaining the 4′-O-mycarosyl moiety (tylosin, DMT) had relatively poor activity against Pasteurella in vitro. Certain 20-modified derivatives of desmycosin demonstrated good oral bioavailability in chicks and a lead compound with oral efficacy in the Pasteurella infection model was discovered. © 1988, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Kirst, H. A., Ose, E. E., Toth, J. E., Willard, K. E., Debono, M., Felty-Duckworth, A. M., & Pekarek, R. S. (1988). In vitro and in vivo evaluation of C-20- and C-23-modified derivatives of tylosin against veterinary pathogens. The Journal of Antibiotics, 41(7), 938–948. https://doi.org/10.7164/antibiotics.41.938

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free